{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360861292452363776.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jddst.2020.102046"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1773224720313356?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1773224720313356?httpAccept=text/plain"}}],"dc:title":[{"@value":"Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380861292452363648","@type":"Researcher","foaf:name":[{"@value":"Mallesh Kurakula"}]},{"@id":"https://cir.nii.ac.jp/crid/1380861292452363776","@type":"Researcher","foaf:name":[{"@value":"G.S.N. Koteswara Rao"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"17732247"}],"prism:publicationName":[{"@value":"Journal of Drug Delivery Science and Technology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2020-12","prism:volume":"60","prism:startingPage":"102046"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","https://doi.org/10.15223/policy-017","https://doi.org/10.15223/policy-037","https://doi.org/10.15223/policy-012","https://doi.org/10.15223/policy-029","https://doi.org/10.15223/policy-004"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1773224720313356?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1773224720313356?httpAccept=text/plain"}],"createdAt":"2020-09-01","modifiedAt":"2025-10-29","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050304936198780800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Fabrication and mechanical/biological evaluations of dissolving bird-bill microneedle arrays"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017279874037376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A starch-based, crosslinked blend film with seawater-specific dissolution characteristics"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390569724160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Formation and Characterization of <i>Z</i>-Isomer-Enriched Carotenoid-Loaded Microparticles with Poly(vinylpyrrolidone) Using a Spray Drying Technique"}]},{"@id":"https://cir.nii.ac.jp/crid/1390576358101904256","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Delayed leukoencephalopathy and subsequent small ischemia after endovascular treatment in a patient with cerebral aneurysm"},{"@language":"ja","@value":"脳動脈瘤塞栓術後に遅発性白質病変が出現し微小虚血巣が遺残した1例"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jddst.2020.102046"},{"@type":"CROSSREF","@value":"10.3995/jstroke.11050_references_DOI_cirgC0rhgAu0jTUkYUlushdZHW"},{"@type":"CROSSREF","@value":"10.1016/j.carbpol.2022.120181_references_DOI_cirgC0rhgAu0jTUkYUlushdZHW"},{"@type":"CROSSREF","@value":"10.1021/acs.iecr.3c03450_references_DOI_cirgC0rhgAu0jTUkYUlushdZHW"},{"@type":"CROSSREF","@value":"10.1007/s13346-024-01757-w_references_DOI_cirgC0rhgAu0jTUkYUlushdZHW"}]}